诺贝尔奖获奖光遗传学研究催生失明和阿尔茨海默病实验性疗法
STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
2026年诺贝尔医学奖授予Karl Deisseroth、Peter Hegemann和Georg Nagel,表彰其开发光遗传学工具;相关研究已催生针对失明和阿尔茨海默病的实验性疗法。Deisseroth表示,大脑由数十亿神经元构成,需要快速且能靶向特定细胞类型的工具。
![]()
![]()
Annalisa (Nalis) Merelli is focused on boys’ and men’s health: She looks into reproductive health, trending treatments, screening approaches, mental health, and everything in between.
It is probably impossible to overstate how complex a brain is: A network of billions of intertwined neurons forming an intricate anatomy, capable of working on the millisecond scale to perceive reality, detect sensations, create plans, and take actions.
“All of this is incredibly complicated, and so of course the challenge that we face as neuroscientists and as physicians treating brain disorders is how can we hope to make headway without tools that match the complexity and the precision of the brain?” said Karl Deisseroth, a Stanford University and Howard Hughes Medical Institute researcher who on Monday won the 2026 Nobel Prize for Medicine, alongside German colleagues Peter Hegemann and Georg Nagel, for work developing such tools.
“Our perception of reality and all our inner subjective states come from cells, and so the appropriate tool that would be matched to how the brain works would be something that was fast and could be targeted to individual cells or individual types of cells,” he said in an interview after the announcement.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
来源:STAT 主站 · statnews.com